Abstract

PURPOSE OF REVIEW

For patients with early stage non-small-cell lung cancer (NSCLC), thermal ablation (TA) has become in the least two decades an option of treatment used worldwide for patients with comorbidities who are not surgical candidates. Here, we review data published with different TA techniques: radiofrequency ablation (RFA), microwave ablation (MWA) and cryoablation. This paper reviews also the comparison that has been made between TA and stereotactic radiotherapy (SBRT).

RECENT FINDINGS

A majority of retrospective studies, the absence of comparative studies, and the variety of techniques make difficult to get evident data. Nevertheless, these stand-alone techniques have demonstrated local efficacy for tumors less than 3 cm and good tolerance on fragile patients. Many recent reviews and database analyses show that outcomes after TA (mainly RFA and MWA) are comparable to SBRT in terms of survival rates. For patients who are unfit for surgery, TA has demonstrated interesting results for safety, benefits in overall survival, and acceptable local control.

MeSH

Lung, Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Cited by

• Cryoablation in the treatment of early breast cancer: a comprehensive analysis. Front Oncol, 2025
• A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablation. J Thorac Dis, 2022
• Cryoablation and immune synergistic effect for lung cancer: A review. Front Immunol, 2022
• Modern cancer therapy: cryoablation meets immune checkpoint blockade. Front Oncol, 2024
• Risk prediction of intraoperative pain in percutaneous microwave ablation of lung tumors under CT guidance. Eur Radiol, 2023
• Issues and prospects of image-guided thermal ablation in the treatment of primary and metastatic lung tumors. Thorac Cancer, 2023
• CT-guided Percutaneous Microwave Ablation Combined with Local Radiotherapy or Chemotherapy of Malignant Pulmonary Tumors. Curr Radiopharm, 2024
• Image-guided percutaneous ablation for lung malignancies. Front Oncol, 2022
• [Research Progress of Treatment for NSCLC in Young Patients]. Zhongguo Fei Ai Za Zhi, 2023
• An Interventional Radiologist's Guide to Lung Cancer. Semin Intervent Radiol, 2024
• CT perfusion imaging can detect residual lung tumor early after radiofrequency ablation: a preliminary animal study on both tumoral and peri-tumoral region assessment. J Thorac Dis, 2022